Skip to main content
. Author manuscript; available in PMC: 2017 Jan 20.
Published in final edited form as: Nucl Med Biol. 2016 Sep 2;43(12):743–751. doi: 10.1016/j.nucmedbio.2016.08.018

Fig. 4.

Fig. 4

Time–activity curves (TACs) in the pancreas from a control scan (closed circles) and a displacement scan (open circles) of 18F-FP-(+)-DTBZ (A–D) and 18F-FP-(−)-DTBZ (E and F). Displacing agents are unlabeled FP-(+)-DTBZ (0.5 mg/kg) (A and E), unlabeled FP-(−)-DTBZ (0.5 mg/kg) (B and F), and fluvoxamine (3 mg/kg) (C and D), administered as an i.v. bolus at 90 min after radioligand injection. For the fluvoxamine displacement study, TACs from the displacement portions of the scan were corrected for body motion. Radioactivity concentrations are expressed in SUV units (concentration/ (injected dose/body weight)).